Enzyme-Triggered In Situ Assembly of Fe3O4 Nanozyme Synthesis Enables Portable Point-of-Care Detection of Acid Phosphatase
Biosensors · 2026
DOI: 10.3390/bios16060337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2026. Verfasst von Jianjun Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Institute of Materia Medica, School of Pharmacy, Fujian Medical University, Fuzhou…. Hauptthemen laut MEDLINE: Acid Phosphatase, Biosensing Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Fujian Provincial Key Laboratory of Hepatic Drug Research.
Abstract (Originalsprache)
Acid phosphatase (ACP) is a clinically important enzyme whose early-stage detection is hindered by its extremely low abundance, nonspecific tissue distribution, and rapid loss of activity under conventional analytical conditions. Herein, we present a target-driven in situ nanozyme synthesis strategy that enables rapid and ultrasensitive point-of-care testing (POCT) of ACP. In this approach, ACP catalyzes the hydrolysis of L-ascorbic acid 2-phosphate sesquimagnesium (AAPS), producing ascorbic acid (AA). The generated AA partially reduces Fe3+ ions to Fe2+, thereby initiating alkaline co-precipitation and in situ formation of Fe3O4 nanoparticles. Polyvinylpyrrolidone (PVP) stabilizes the nanoparticles and preserves catalytic accessibility, while their intrinsic magnetism allows for efficient magnetic separation to eliminate matrix interference. The resulting Fe3O4@PVP nanozymes display pronounced peroxidase-like activity, catalyzing hydrogen-peroxide-mediated oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB). Quantitative readout can be achieved using either spectrophotometric analysis or smartphone imaging. The sensing platform achieves a detection limit of 0.021 U/L within 40 min and demonstrates excellent sensitivity, selectivity, and operational robustness. Successful validation in human serum confirms its clinical feasibility, while smartphone-based imaging enables portable and low-cost quantification suitable for decentralized diagnostics. Collectively, this work establishes a generalizable paradigm for target-triggered nanozyme generation aimed at detecting low-abundance and labile biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Institute of Materia Medica, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China.
- Department of Gastroenterology, Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, China.
ORCID-Profile: Yuanchun Chen, Fang Ke
Förderung
- Natural Science Foundation of Fujian Province
- Fujian Provincial Key Laboratory of Hepatic Drug Research
Zitieren
APA
Kang, J., Chen, Y., Shu, Z., Wu, C., & Ke, F. (2026). Enzyme-Triggered In Situ Assembly of Fe3O4 Nanozyme Synthesis Enables Portable Point-of-Care Detection of Acid Phosphatase. Biosensors. https://doi.org/10.3390/bios16060337
Vancouver
Kang J, Chen Y, Shu Z, Wu C, Ke F. Enzyme-Triggered In Situ Assembly of Fe3O4 Nanozyme Synthesis Enables Portable Point-of-Care Detection of Acid Phosphatase. Biosensors. 2026. doi:10.3390/bios16060337
BibTeX
@article{Kang2026,
author = {Kang, Jianjun and Chen, Yuanchun and Shu, Zongcheng and Wu, Cuimin and Ke, Fang},
title = {Enzyme-Triggered In Situ Assembly of Fe3O4 Nanozyme Synthesis Enables Portable Point-of-Care Detection of Acid Phosphatase},
journal = {Biosensors},
year = {2026},
doi = {10.3390/bios16060337}
}
EUVIMED